Stay updated on Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe record history shows a new Revision: v3.7.0 replacing the previous v3.6.6, indicating a page version update rather than changes to the study details.SummaryDifference0.1%

- Check36 days agoChange DetectedA new revision entry v3.6.6 was added to the record history, and the previous revision v3.6.5 was removed from the history.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry (v3.6.5) was added to the study record history, and the previous revision (v3.6.4) was removed from the current listing, indicating a platform version update rather than content changes.SummaryDifference0.1%

- Check71 days agoChange DetectedA new site release version, v3.6.4, is added to the record history, replacing the previous release v3.6.3.SummaryDifference0.1%

- Check93 days agoChange DetectedThe record history now shows a new revision tag, v3.6.3, while the previous tag v3.6.2 is removed. This indicates an update to the study record’s version, rather than a change to the study’s content or eligibility.SummaryDifference0.1%

- Check100 days agoChange DetectedThe page’s Revision tag was updated from v3.6.0 to v3.6.2, signaling a backend software release. This update underpins the page without changing the displayed study information.SummaryDifference0.1%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.